All News

Roche has announced that phase 3 results from the OAK study evaluating atezolizumab (Tecentriq) indicate improved overall survival compared with docetaxel in patients with locally advanced or metastatic non—small cell lung cancer.

What we're reading, September 1, 2016: new, stronger warnings on opioid labels; why competition hasn't curbed drug price hikes; and Zika funding bill likely won't pass the Senate.

Since New Jersey's Republican governor shares power with a Democratic legislature, acceptance-if not full-throated support of Medicaid expansion-was not a surprise in 2013. But this week's event was seen by political observers as a sign Christie wants to be compared with Ohio's John Kasich.

A new report by the law firm Frier Levitt, commissioned by the Community Oncology Alliance, has found that restrictive tactics by pharmacy benefit managers, particularly in the specialty pharmacy arena, could restrict patient access to much needed medications.

A nationwide telemedicine diabetic screening program could help prevent diabetic retinopathy, the top cause of new-onset blindness in the United States.

Researchers and patients alike are increasingly interested in therapies that do more to limit the day-to-day, and hour-to-hour fluctuations in blood glucose that consume the time and energy of those living with diabetes.

While the majority of the adults infected with hepatitis C virus are baby boomers-people between the ages of 51 and 71 years-Alaska is seeing a large spike in infection rates among young adults.

What we're reading, August 31, 2016: 51% of Americans have a negative view of the pharmaceutical industry; the CDC is running out of funds to fight the Zika virus; and Pennsylvania chooses 3 private companies to manage Medicaid plans.

Erelzi, developed by Sandoz has been approved for use against a number of inflammatory conditions, including rheumatoid arthritis and plaque psoriasis.

The authors are among those concerned that patients with diabetes may be given more medication than they can tolerate or afford to achieve small improvements in A1C, without any other health benefits.

A new study on the racial differences in patient experience revealed black patients reported better experience than whites do, even though they were less likely to recommend hospitals.

Scientists at Brigham and Women’s Hospital are evaluating the depth of a trained radiologist’s eye to detect abnormalities on a mammogram, in an attempt to improve screening and earlier detection of disease.

What We're Reading, August 30, 2016: the Justice Department is investigating police treatment of the mentally ill; researchers identify overtreatment based on imaging procedures; and 2 drug compounds may prevent the Zika virus from replicating in the body.

CMS' new proposal to shore up the Affordable Care Act (ACA) marketplaces signals that federal officials have heard concerns that not enough has been done to prevent adverse selection or share risk for the sickest patients who gained coverage under the ACA.

A study found that the longer a woman is overweight or obese, the higher the risk of developing several forms of cancer, plus the degree of being overweight plays a role in the risk of developing cancer.

Researchers at Cancer Research UK have developed a strategy to make pancreatic cancer more responsive to chemotherapy and radiation.

In the August issue of Evidence-Based Oncology, The Samfund's Samantha Watson, MBA, and Michelle Landwehr, MPH, outline how young adult cancer survivors are disproportionately affected by treatment costs. This infographic breaks down the vicious cycle these patients get stuck in.

A vaccine, under development in Cuba for more than 2 decades, has shown potential to improve survival in patients with advanced non-small cell lung cancer.

Payer coverage has been cited as the most frequent barrier to patient access to obesity therapy. While most new obesity therapies have lower wholesale costs than SGLT2 inhibitors, lack of coverage puts them out of reach for most Americans, according to a new study.

Kentucky Governor Matt Bevin's updated Medicaid proposal relies on beneficiaries being active consumers in their healthcare, but evidence shows that will be unlikely, especially among those with low incomes.

What we're reading, August 29, 2016: Audit finds Medicare Advantage plans overcharged the government; enrollment on the Affordable Care Act's exchanges less than half of initial prediction; and California bill to protect consumers from surprise medical bills divides physicians.

High-density lipoprotein (HDL) has become known as “good cholesterol” because it helps reduce risk of stroke and heart attack. However, new research found that both high and low levels of HDL could increase a person’s risk of premature death.

Despite coverage gains since the implementation of the Affordable Care Act, groups at risk of being uninsured before the law continue to have higher uninsured rates.

Programs that seek to lower hospital admissions rates may also reduce readmissions, even though patients in communities adopting the programs tend to be sicker when hospitalized, according to a recent study in Health Affairs.

This week in managed care, the top stories included new reports on a 10-year experiment in payment reform, more results from the early years of the Affordable Care Act, and findings on employee wellness programs.

High persistent spending is unusually common during the year before death, researchers find.

Researchers found a dose-response relationship for several cancers involved in eating, meaning the higher the weight, the greater risk of cancer.

Advances in genetic technologies have a great potential to be used to advance treatments, especially through personalized medicine. However, there are concerns that disadvantaged groups do not have access to these advances.

Margaret E. O'Kane has been making lasting impacts on healthcare quality measurement for years. But when she founded the National Committee for Quality Assurance, the organization was sometimes underestimated and not taken seriously.